Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1046/j.1365-2036.2000.00740.x http://scihub22266oqcxt.onion/10.1046/j.1365-2036.2000.00740.x 10792112!ä!10792112 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Aliment+Pharmacol+Ther 2000 ; 14 (5): 515-21 Nephropedia Template TP {{tp|p=10792112|t=2000. Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients |pdf=|usr=}}{{10792112}} gab.com Text Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients JO: Aliment Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=10792112 #FOAvip Renal failure is common in patients who are dying from end-stage cirrhosis, developing in 40-80% of all patients. Where there is no anatomical or pathological cause for the renal failure, it is termed the hepatorenal syndrome. When the hepatorenal syndrome develops, it will only recover when there is some degree of improvement in liver function. Thus for most patients this will occur only after liver transplantation, although the transplantation mortality is increased in this group. Hepatorenal syndrome is a common complication of alcoholic hepatitis, and this group is unusual in that with time and abstinence, significant recovery of liver function may occur. There is therefore a need for supportive therapy to allow time for some recovery of liver function in patients with alcoholic hepatitis and hepatorenal syndrome. Similarly, patients may need support whilst waiting for liver transplantation. This article reviews the pathophysiology and treatment of hepatorenal syndrome. Twit Text FOAVip Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients ????Aliment Pharmacol Ther http://www.kidney.de/pget.php?&tw=1&pmid=10792112 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=10792112 #FOAvip English Wikipedia <ref>{{Cite pmid|10792112}}</ref> Review article: pharmacological treatment of the hepatorenal syndrome in cirrhotic patients #MMPMID10792112 Dagher L; Patch D; Marley R; Moore K; Burroughs A Aliment Pharmacol Ther 2000[May]; 14 (5): 515-21 PMID10792112show ga Renal failure is common in patients who are dying from end-stage cirrhosis, developing in 40-80% of all patients. Where there is no anatomical or pathological cause for the renal failure, it is termed the hepatorenal syndrome. When the hepatorenal syndrome develops, it will only recover when there is some degree of improvement in liver function. Thus for most patients this will occur only after liver transplantation, although the transplantation mortality is increased in this group. Hepatorenal syndrome is a common complication of alcoholic hepatitis, and this group is unusual in that with time and abstinence, significant recovery of liver function may occur. There is therefore a need for supportive therapy to allow time for some recovery of liver function in patients with alcoholic hepatitis and hepatorenal syndrome. Similarly, patients may need support whilst waiting for liver transplantation. This article reviews the pathophysiology and treatment of hepatorenal syndrome. |Disease Progression[MESH] |Felypressin/therapeutic use[MESH] |Hepatitis, Alcoholic/complications[MESH] |Hepatorenal Syndrome/etiology/physiopathology/*therapy[MESH] |Humans[MESH] |Liver Cirrhosis/*complications[MESH] |Liver Transplantation[MESH] |Lypressin/analogs & derivatives/therapeutic use[MESH] |Octreotide/therapeutic use[MESH] |Renal Agents/therapeutic use[MESH] |Terlipressin[MESH]Review article: pharmacological treatment of the hepatorenal syndrome (epmc).pdf DeepDyve Pubget Overpricing